Irbesartan vs Moxifloxacin
Irbesartan vs Moxifloxacin: Overview
This comparison examines the pharmacological differences between Irbesartan and Moxifloxacin.
Mechanism of Action
Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.
Moxifloxacin: Fourth-generation fluoroquinolone inhibiting DNA gyrase and topoisomerase IV with enhanced anaerobic activity.
Pharmacokinetics
Half-life: Irbesartan β 11-15 hours; Moxifloxacin β 12 hours.
Chemical Properties
Molecular Formula: Irbesartan β C25H28N6O; Moxifloxacin β C21H24FN3O4.
Molecular Weight: Irbesartan β 428.5320 g/mol; Moxifloxacin β 401.4350 g/mol.
Type: Irbesartan β Small molecule; Moxifloxacin β Small molecule.